A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy - Konmun, J; Danwilai, K; Ngamphaiboon, N (Med Oncol, 2017)
et al